家长对 2020 年至 2023 年儿童和青少年接种 SARS-CoV-2 疫苗的决定:对加拿大蒙特利尔家长和儿童的描述性纵向研究。

IF 4.5 3区 医学 Q2 IMMUNOLOGY
Katia Charland , Caroline Quach , Jesse Papenburg , Laura Pierce , Cat Tuong Nguyen , Adrien Saucier , Margot Barbosa Da Torre , Marie-Ève Hamelin , Julie Carbonneau , Guy Boivin , Kate Zinszer
{"title":"家长对 2020 年至 2023 年儿童和青少年接种 SARS-CoV-2 疫苗的决定:对加拿大蒙特利尔家长和儿童的描述性纵向研究。","authors":"Katia Charland ,&nbsp;Caroline Quach ,&nbsp;Jesse Papenburg ,&nbsp;Laura Pierce ,&nbsp;Cat Tuong Nguyen ,&nbsp;Adrien Saucier ,&nbsp;Margot Barbosa Da Torre ,&nbsp;Marie-Ève Hamelin ,&nbsp;Julie Carbonneau ,&nbsp;Guy Boivin ,&nbsp;Kate Zinszer","doi":"10.1016/j.vaccine.2024.126489","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Given the growing evidence on the benefits of hybrid immunity, continued monitoring of vaccine uptake is warranted, particularly of socio-demographic subgroups with early vaccine hesitancy. Racial/ethnic and lower income groups experienced a high infection incidence, but few studies account for the child's history of SARS-CoV-2 infection on the parent's decision to vaccinate their child.</div></div><div><h3>Methods</h3><div>EnCORE is a SARS-CoV-2 pediatric cohort study comprising five rounds of data collection from 2020 to 2023, with parental questionnaires at each round. Parent's responses on their intention to vaccinate their child and their reasons were summarized descriptively. Vaccine uptake was estimated through time and in relation to participant characteristics, using multivariable regression to adjust for covariates including a history of PCR/serology-confirmed SARS-CoV-2 infection prior to vaccine eligibility. At study end, we estimated the average time lapsed from last vaccine dose.</div></div><div><h3>Results</h3><div>The samples for vaccine uptake and intention to vaccinate analyses were 631 and 1137 participants, respectively. At study end, uptake was 88 % but approximately 49 % of 2-to-4-year-olds remained unvaccinated (95 % CI 39.0, 58.1) and for vaccinated participants the median time since last vaccination was 353 days. In regression analyses, after adjusting for infection prior to vaccine eligibility and other covariates, we found approximately a two-fold increase in unvaccinated status associated with the parent's identification as a racial/ethnic minority and with household income in the lowest sample tercile (minority: adjusted relative risk [aRR] 2.45, 95 % CI 1.56, 3.86; income: aRR 1.76, 95 % CI 1.17, 2.66).</div></div><div><h3>Conclusion</h3><div>By mid-2023, most participants were not protected by vaccine-induced antibodies, because they were unvaccinated or several months had lapsed from their last dose. A COVID-19 infection prior to vaccine eligibility was associated with a greater risk of remaining unvaccinated but did not fully account for low uptake in ethnic/racial minorities and lower income groups.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"43 ","pages":"Article 126489"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Parental decisions regarding the vaccination of children and adolescents against SARS-CoV-2 from 2020 to 2023: A descriptive longitudinal study of parents and children in Montreal, Canada\",\"authors\":\"Katia Charland ,&nbsp;Caroline Quach ,&nbsp;Jesse Papenburg ,&nbsp;Laura Pierce ,&nbsp;Cat Tuong Nguyen ,&nbsp;Adrien Saucier ,&nbsp;Margot Barbosa Da Torre ,&nbsp;Marie-Ève Hamelin ,&nbsp;Julie Carbonneau ,&nbsp;Guy Boivin ,&nbsp;Kate Zinszer\",\"doi\":\"10.1016/j.vaccine.2024.126489\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Given the growing evidence on the benefits of hybrid immunity, continued monitoring of vaccine uptake is warranted, particularly of socio-demographic subgroups with early vaccine hesitancy. Racial/ethnic and lower income groups experienced a high infection incidence, but few studies account for the child's history of SARS-CoV-2 infection on the parent's decision to vaccinate their child.</div></div><div><h3>Methods</h3><div>EnCORE is a SARS-CoV-2 pediatric cohort study comprising five rounds of data collection from 2020 to 2023, with parental questionnaires at each round. Parent's responses on their intention to vaccinate their child and their reasons were summarized descriptively. Vaccine uptake was estimated through time and in relation to participant characteristics, using multivariable regression to adjust for covariates including a history of PCR/serology-confirmed SARS-CoV-2 infection prior to vaccine eligibility. At study end, we estimated the average time lapsed from last vaccine dose.</div></div><div><h3>Results</h3><div>The samples for vaccine uptake and intention to vaccinate analyses were 631 and 1137 participants, respectively. At study end, uptake was 88 % but approximately 49 % of 2-to-4-year-olds remained unvaccinated (95 % CI 39.0, 58.1) and for vaccinated participants the median time since last vaccination was 353 days. In regression analyses, after adjusting for infection prior to vaccine eligibility and other covariates, we found approximately a two-fold increase in unvaccinated status associated with the parent's identification as a racial/ethnic minority and with household income in the lowest sample tercile (minority: adjusted relative risk [aRR] 2.45, 95 % CI 1.56, 3.86; income: aRR 1.76, 95 % CI 1.17, 2.66).</div></div><div><h3>Conclusion</h3><div>By mid-2023, most participants were not protected by vaccine-induced antibodies, because they were unvaccinated or several months had lapsed from their last dose. A COVID-19 infection prior to vaccine eligibility was associated with a greater risk of remaining unvaccinated but did not fully account for low uptake in ethnic/racial minorities and lower income groups.</div></div>\",\"PeriodicalId\":23491,\"journal\":{\"name\":\"Vaccine\",\"volume\":\"43 \",\"pages\":\"Article 126489\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0264410X2401171X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X2401171X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:鉴于越来越多的证据表明混合免疫的益处,有必要对疫苗接种率进行持续监测,尤其是对早期对疫苗犹豫不决的社会人口亚群。种族/民族和低收入群体的感染率较高,但很少有研究考虑到儿童的 SARS-CoV-2 感染史会影响父母是否为其子女接种疫苗:EnCORE是一项SARS-CoV-2儿科队列研究,从2020年到2023年共收集了五轮数据,每轮都对家长进行了问卷调查。对家长关于是否打算为孩子接种疫苗及其原因的回答进行了描述性总结。疫苗接种率是通过时间和参与者特征来估算的,采用多变量回归法来调整协变量,包括在获得疫苗接种资格之前的 PCR/血清学证实的 SARS-CoV-2 感染史。研究结束时,我们估算了距最后一次接种疫苗的平均时间:用于疫苗接种率和接种意向分析的样本分别为 631 人和 1137 人。研究结束时,接种率为 88%,但仍有约 49% 的 2-4 岁儿童未接种疫苗(95 % CI 39.0, 58.1),接种过疫苗的参与者距上次接种疫苗的时间中位数为 353 天。在回归分析中,在调整了疫苗接种资格之前的感染情况和其他协变量后,我们发现未接种疫苗的情况大约增加了两倍,这与父母被认定为少数种族/族裔以及最低样本三元组中的家庭收入有关(少数种族:调整后相对风险 [aRR] 2.45,95 % CI 1.56,3.86;收入:aRR 1.76,95 % CI 1.17,2.66):到 2023 年中期,大多数参与者都没有受到疫苗诱导抗体的保护,因为他们没有接种疫苗,或者距离最后一次接种疫苗已经过去了几个月。在获得疫苗接种资格之前感染 COVID-19 与未接种疫苗的更大风险有关,但这并不能完全解释少数民族和低收入群体接种率低的原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Parental decisions regarding the vaccination of children and adolescents against SARS-CoV-2 from 2020 to 2023: A descriptive longitudinal study of parents and children in Montreal, Canada

Background

Given the growing evidence on the benefits of hybrid immunity, continued monitoring of vaccine uptake is warranted, particularly of socio-demographic subgroups with early vaccine hesitancy. Racial/ethnic and lower income groups experienced a high infection incidence, but few studies account for the child's history of SARS-CoV-2 infection on the parent's decision to vaccinate their child.

Methods

EnCORE is a SARS-CoV-2 pediatric cohort study comprising five rounds of data collection from 2020 to 2023, with parental questionnaires at each round. Parent's responses on their intention to vaccinate their child and their reasons were summarized descriptively. Vaccine uptake was estimated through time and in relation to participant characteristics, using multivariable regression to adjust for covariates including a history of PCR/serology-confirmed SARS-CoV-2 infection prior to vaccine eligibility. At study end, we estimated the average time lapsed from last vaccine dose.

Results

The samples for vaccine uptake and intention to vaccinate analyses were 631 and 1137 participants, respectively. At study end, uptake was 88 % but approximately 49 % of 2-to-4-year-olds remained unvaccinated (95 % CI 39.0, 58.1) and for vaccinated participants the median time since last vaccination was 353 days. In regression analyses, after adjusting for infection prior to vaccine eligibility and other covariates, we found approximately a two-fold increase in unvaccinated status associated with the parent's identification as a racial/ethnic minority and with household income in the lowest sample tercile (minority: adjusted relative risk [aRR] 2.45, 95 % CI 1.56, 3.86; income: aRR 1.76, 95 % CI 1.17, 2.66).

Conclusion

By mid-2023, most participants were not protected by vaccine-induced antibodies, because they were unvaccinated or several months had lapsed from their last dose. A COVID-19 infection prior to vaccine eligibility was associated with a greater risk of remaining unvaccinated but did not fully account for low uptake in ethnic/racial minorities and lower income groups.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vaccine
Vaccine 医学-免疫学
CiteScore
8.70
自引率
5.50%
发文量
992
审稿时长
131 days
期刊介绍: Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信